Oxytocin Fails to Recruit Serotonergic Neurotransmission in the Autistic Brain. (17th October 2017)

• Record Type: Journal Article
• Authors: Lefevre, Arthur; Mottolese, Raphaëlle; Redouté, Jérôme; Costes, Nicolas; Le Bars, Didier; Geoffray, Marie-Maude; Leboyer, Marion; Sirigu, Angela
• Is Part Of: Cerebral cortex. Volume 28:Number 12(2018)
• Page Start: 4169
• Page End: 4178
• Publication Date: 2017-10-17
• Subjects: Autism -- Oxytocin -- PET-scan -- Serotonin; Cerebral cortex -- Periodicals; Brain -- Periodicals; 612.825
• DOI: 10.1093/cercor/bhx272
• Languages: English
• ISSNs: 1047-3211

Abstract

Abstract: Oxytocin (OT), a neuropeptide involved in affiliation has been shown to enhance social skills in patients with autism spectrum disorders (ASD). Nevertheless, OT improvements seem ephemeral. Animal research has demonstrated OT action on serotonin (5-HT), an interaction that we also found in the healthy human brain. Whether such synaptic interplay also occurs in ASD patients is unknown. To address this issue, we mapped the effects of intranasal OT on 5-HT in 18 patients with ASD and 24 healthy controls (HC) in a double blind, placebo controlled, within subject PET-scan experiment. Each participant underwent two scans: baseline and spray (OT or placebo). Using the radiotracer [18 F]MPPF, marking the 5-HT 1A receptor (5-HT1A R), we measured MPPF-Binding Potential (BP) as an index of OT-induced serotonin functional modulation. At baseline ASD patients did not differ from controls for 5-HT1A R concentration and distribution. However, while OT significantly increased MPPF BP in several brain regions of HC, no changes were observed in the ASD group. Serotonin serum concentration analysis corroborated these results. Our findings suggest a disturbed OT-serotonin interaction in autism. This may limit the potential benefits of OT in these patients and open the ways to investigate combined OT-serotonin treatments.